Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q3 2018 Earnings

7AugConfirmed

Q4 2017

Q1 2018

Q2 2018

Q3 2018

-0.23

0.13

0.49

0.85

Details

Expected EPS

-0.22

Actual EPS

-0.16

Surprise EPS

0.06

Surprise Percent

+27.27%

Description

Halozyme Therapeutics (HALO) has reported earnings of -0.16 per share for Q3 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.